Godavari Biorefineries Share Price

Specialty Chemicals company Godavari Biorefineries announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: For Q4FY26, the revenue stood at Rs 56,410.30 lakh, showing a growth of 22.67% compared to Rs 45,985.25 lakh in Q3FY26 (QoQ) and a decline of 2.66% compared to Rs 57,950.45 lakh in Q4FY25 (YoY). For the full year FY26, the revenue increased to Rs 1,98,794.26 lakh compared to Rs 1,87,025.12 lakh in FY25. Total Income: For Q4FY26, total income was Rs 57,000.07 lakh, up 23.40% from Rs 46,190.85 lakh in Q3FY26 (QoQ) and down 3.19% from Rs 58,875.84 lakh in Q4FY25 (YoY). For the full year FY26, total income reached Rs 2,00,015.34 lakh compared to Rs 1,88,691.38 lakh in FY25. Profit / (Loss) After Tax: For Q4FY26, the profit after tax was Rs 5,288.48 lakh, representing a significant increase of 540.85% from Rs 825.24 lakh in Q3FY26 (QoQ) and a decrease of 26.47% from Rs 7,192.77 lakh in Q4FY25 (YoY). For the full year FY26, the company reported a profit of Rs 352.80 lakh, compared to a loss of Rs 2,341.44 lakh in FY25. Earnings Per Share (EPS): Basic and Diluted EPS for Q4FY26 stood at Rs 10.33, compared to Rs 1.61 in Q3FY26 and Rs 14.05 in Q4FY25. For the full year FY26, EPS was Rs 0.69 compared to a negative Rs 5.11 in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, revenue was Rs 56,210.57 lakh, an increase of 23.03% from Rs 45,688.15 lakh in Q3FY26 (QoQ) and a marginal decline of 2.36% from Rs 57,569.85 lakh in Q4FY25 (YoY). For the full year FY26, revenue stood at Rs 1,96,492.02 lakh compared to Rs 1,85,316.64 lakh in FY25. Total Income: For Q4FY26, total income was Rs 56,786.14 lakh, up 23.80% from Rs 45,868.96 lakh in Q3FY26 (QoQ) and down 2.95% from Rs 58,511.31 lakh in Q4FY25 (YoY). For the full year FY26, total income was Rs 1,97,638.50 lakh compared to Rs 1,86,920.56 lakh in FY25. Profit / (Loss) After Tax: For Q4FY26, profit after tax was Rs 5,241.13 lakh, up 547.41% from Rs 809.58 lakh in Q3FY26 (QoQ) and down 25.21% from Rs 7,008.00 lakh in Q4FY25 (YoY). For the full year FY26, the standalone profit was Rs 123.62 lakh compared to a loss of Rs 2,715.95 lakh in FY25. Business Highlights Segment Performance (Consolidated Full Year FY26): Sugar: Reported total revenue of Rs 1,27,945.04 lakh with a segment result (PBIT) of Rs 4,969.47 lakh. Cogeneration: Reported total revenue of Rs 16,028.08 lakh and a segment loss of Rs 350.68 lakh. Bio based Chemicals: Reported total revenue of Rs 57,798.89 lakh with a segment result of Rs 3,632.15 lakh. Distillery: Reported total revenue of Rs 66,364.97 lakh with a segment result of Rs 947.22 lakh. Operational Achievements: Achieved the highest-ever cane crushing performance of 25.18 lakh MT during the 2025-26 season. The 2024-25 season achieved a record crushing of 24.65 lakh MT. Exceptional Items: The company recognized a one-time exceptional expense of Rs 448.22 lakh related to the implementation of the New Labour Codes and their impact on Gratuity and Leave Encashment. Recognized an exceptional expense of Rs 2,665.59 lakh for additional harvest charges related to the 2023-2024 sugar season to remain competitive with neighboring mills. Leadership and Governance: Approved the re-appointment of Mr Samir S. Somaiya as Managing Director for three years w.e.f. April 1, 2027. Approved the re-appointment of Dr Sangeeta Srivastava as Executive Director for three years w.e.f. August 1, 2026. Approved the re-appointment of Mr Nitin Mehta as Independent Director for a second term of five years w.e.f. July 1, 2026. Approved the appointment of Mr Dinesh Sharma as Whole Time Director (designated as Executive Director and KMP) for three years. Appointed M/s R. Nanabhoy & Co, Cost Accountants, as Cost Auditor for the FY27. Commenting on the Results, Shri Samir Somaiya, CMD, said, “Q4FY26 was marked by a challenging operating environment for the sugar and ethanol industry, with elevated cane and feedstock costs impacting overall sector profitability. Against this backdrop, our integrated business model, operational discipline and diversified portfolio enabled us to deliver a resilient performance during the quarter while continuing to strengthen our long-term growth platforms. During the 2025-26 crushing season, we achieved our highest-ever cane crushing of 2.5 million tonnes. The Sugar business witnessed improved operational performance during the quarter, supported by higher crushing volumes, improved recovery trends and strong execution in exports. Our continued focus on operational efficiencies helped support segment performance despite the broader industry challenges. The sugar & ethanol segment continued to operate in a relatively compressed margin environment due to feedstock economics and pricing dynamics. However, the long-term outlook for the industry remains positive supported by the Government’s ethanol blending programme and stable policy direction.The Bio-based Chemicals segment recorded meaningful contributions from specialty chemicals, with ethyl acetate realizations remained favorable, though emerging geopolitical disruptions impacted operating margins. We remain focused on increasing the share of higher-margin specialty products and improving capacity utilization across the portfolio. During the quarter, we further strengthened our innovation portfolio with the grant of a Japanese patent related to antiviral therapeutics, reinforcing our R&D; capabilities. We are also encouraged by the continued momentum in our consumer business, with Jivana revenues crossing Rs 129 crore in FY26 compared to Rs 108 crore in FY25. The growing scale of our retail platform reflects increasing consumer acceptance and supports our strategy of building a more diversified and resilient business model alongside our industrial businesses. Looking ahead, we remain focused on scaling our bio-based chemicals and ethanol businesses through debottlenecking, capacity optimization and diversification of feedstock for ethanol production, capitalizing on the Government’s efforts to move beyond E20. In parallel, we continue to expand our high-value bio-based chemicals portfolio by leveraging our integrated R&D; and manufacturing capabilities. Continued investments in technology, process efficiencies and sustainability-led initiatives remain central to our strategy, supporting long-term value creation.” Result PDF

• Trendlyne
• 3 weeks ago

On an annualised basis, the company estimates that its ethanol output will increase from around 10 crore litres to around 16 crore litres after the new facility becomes operational

• Business Line
• 1 month 1 week ago

The patented compounds work by inhibiting Vacuolar ATPase (V-ATPase) activity in cells a host-cell mechanism that viruses exploit during infection and replication

• Business Line
• 2 months 3 weeks ago